Synthetic Biology Market (2025-2032)
The Synthetic Biology Market was valued at $14.88 billion in 2024. This market is expected to reach $80.2 billion by 2032, from an estimated $18.31 billion in 2025, at a CAGR of 23.5% during the forecast period 2025-2032. Synthetic Biology Market Size & Forecast The growth of this market can be
- Published
- Aug 2024
- Pages
- 310
- Format
- PDF + Excel
- Report ID
- MRHC - 1041143
- Base year
- 2024
- 2024 · BASELINE
- $14.88B
- 2032
- $80.20B
- CAGR 2025–2032
- 23.5%
2024 baseline · 2025–2032 forecast at 23.5% CAGR · hover a bar for the value
Key highlights
By Product: In 2025, the Oligonucleotide and Synthetic DNA Segment to Dominate the Synthetic Biology Market
By Technology: In 2025, the Gene Synthesis Segment to Dominate the Synthetic Biology Market
By Application: In 2025, the Life Science & Healthcare Application Segment to Dominate the Synthetic Biology Market
By End User: In 2025, the Pharmaceutical, Biotechnology, & MedTech Companies Segment to Dominate the Synthetic Biology Market
Report summary
| Particulars | Details |
|---|---|
| Number of Pages | 310 |
| Format | |
| Forecast Period | 2025-2032 |
| Base Year | 2024 |
| CAGR | 23.5% |
| Estimated Market Size (Value) | $80.20 billion by 2032 |
| Segments Covered | By Product · Oligonucleotide and Synthetic DNA · Xeno-Nucleic Acids · Enzymes · Cloning Technologies Kits · Chassis Organism · Other Products · (Note: Other products include synthetic cells, enabling kits, and viral expression systems.) · By Technology · Gene Synthesis · Sequencing · Genome Editing · Cloning · Site-Directed Mutagenesis · Bioinformatics · Other Technologies · (Note: Other technologies include nanotechnology, HTS, and microfluidics.) · By Application · Life Science & Healthcare Application · Drug Discovery, Design & Development · Bioprocessing · Therapeutics · Other Life Science & Healthcare Applications · Industrial & Chemical Application · Biofuels · Industrial Enzyme, by End Use · Textile Industry · Paper Industry · Cosmetic Industry · Bioplastics & Green Chemicals · Food & Agriculture Application · Specialty Food · Fertilizers · Environment Application · Biosensing · Bioremediation/Conservation · (Note: Other life science & healthcare applications include IVD test developments, personalized medicines, and biomaterials.) · By End User · Pharmaceutical, Biotechnology, & MedTech Companies · CMOs & CROs · Academic & Research Institutes · Food & Agriculture Industry · Chemical Industry · Environmental Agencies · Other End Users · (Note: Other end users include the textile industry, paper industry, and cosmetics industry.) |
| Countries Covered | North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, Denmark, Switzerland, and Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Rest of Latin America), and Middle East & Africa |
| Key Companies | The key players operating in the global synthetic biology market are Thermo Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), Agilent Technologies, Inc. (U.S.), Novozymes A/S (Denmark), Codexis, Inc. (U.S.), Creative Biogene Inc. (U.S.), Amyris, Inc. (U.S.), Precigen, Inc. (U.S.), Illumina, Inc. (U.S.), New England Biolabs (U.S.), Ginkgo Bioworks (U.S.), Genscript Biotech Corp. (U.S.), Eurofins Scientific SE (France), and Twist Bioscience (U.S.). |
Report overview
Segments covered: product, oligonucleotide, synthetic dna, xeno-nucleic acid, enzyme, cloning technologies kit, chassis organism, other product, technology, gene synthesis, sequencing, genome editing, cloning, site-directed mutagenesis, bioinformatic, other technology, application, life science & healthcare application, drug discovery, design & development, bioprocessing, therapeutic, other life science & healthcare application, industrial & chemical application, biofuel, industrial enzyme, end use, textile industry, paper industry, cosmetic industry, bioplastics & green chemical, food & agriculture application, specialty food, fertilizer, environment application, biosensing, bioremediation/conservation, end user, pharmaceutical, biotechnology, medtech company, cmos & cro, academic & research institute, food & agriculture industry, chemical industry, environmental agency, other end user. Regions: North America, Europe, Asia-Pacific, Latin America.
The growth of this market can be attributed to various factors, such as the declining cost of sequencing, increased funding in synthetic biology, rising application area of synthetic biology, advancements in gene engineering technologies, and rising research on synthetic vaccines. Furthermore, rising R&D funding, rising focus on personalized medicine, increasing demand for biofuel, and innovations in synthetic biology are expected to offer growth opportunities.
Report infographic
Market dynamics
2 factors across 1 forceSynthetic Biology Market Trends
-
Integration of Artificial intelligence (AI) and machine learning (ML) in Synthetic Biology
The major issue facing the synthetic biology industry is the inability to accurately predict biological systems. AI and ML provide the predictive ability required in the synthetic biology process. AI can be used to select the target, design the pathway needed to produce the desired target, help optimize and engineer biological systems, scale up production, and extract the desired product.
Additionally, AI can be used to analyze the effectiveness of microorganism strains created by synthetic biology data and predict whether a strain will scale commercially or not. This will help in the selection of high-quality strains to produce a quality product. Synthetic biology companies are also using AI to cater to various application areas.
-
Increasing Preference for Biofuel
Biofuel is a fuel derived from biomass such as animal waste, plant material, or algae. Since such feedstock material can be readily replaced, biofuel is considered a source of renewable energy, unlike fossil fuels such as natural gas, petroleum, and coal. Synthetic biology can help in biofuel production in two ways, including improving existing methods of biofuel production from plants and generating industrial microbes through engineering host organisms as cell factories, which can generate energy from traditional and non-traditional forms of feedstock.
The demand for biofuel is expected to increase due to the increasing demand for transport fuel, robust biofuel policies, and abundant feedstock potential. According to The International Energy Agency (France), an autonomous intergovernmental organization, the demand for biofuel is expected to increase by 38 billion liters between 2024 and 2028.
Synthetic Biology Market Opportunity
-
Increasing Focus on Personalized Medicine
Personalized/precision medicine uses an individual’s genomic information to offer targeted treatments. As precision medicine is based on individuals’ genetic makeup, it can overcome the limitations of traditional medicines and provide effective treatment. The growing interest in personalized medication, particularly in the fields of gene therapy, cancer, and cell therapy, has increased the need for synthetic biology products. Synthetic biology is used for pathway modeling to understand the mechanisms of cellular signaling and for discovering new therapeutic targets for the treatment of various diseases.
Rising funding for personalized medicine research and growing approvals are creating opportunities to use synthetic biology products in this field.
Table of contents
12 chapters · 128 sections · 310 pages · click to expandSegmental analysis
| Segment | Largest share (2025) | Fastest growth (2025–2032) |
|---|---|---|
| By Product | Oligonucleotide and Synthetic DNA | Enzymes |
| By Technology | Gene Synthesis | — |
| By Application | Life Science & Healthcare Application | — |
| By End User | Pharmaceutical, Biotechnology, & MedTech Companies | — |
By Product
- The oligonucleotide and synthetic DNA segment is expected to account for the largest share of 35% of synthetic biology market.
- The large share of this segment is attributed to the wide use of oligonucleotide and synthetic DNA in biomedical research.
- The versatility and programmability of synthetic DNA and oligonucleotides are increasing their demand in biomedical research.
- For instance, synthetic oligonucleotides are being tested for therapeutic applications to target abnormally expressed genes in case of a wide array of diseases ranging from viral infections to psychoneurological diseases.
- However, the enzymes segment is projected to witness the highest growth rate of 25.6% during the forecast period of 2025–2032.
- Enzymes act as catalysts during biochemical reactions.
- Growing demand for synthetic enzymes in various end-use industries is driving the market growth.
- Synthetic enzymes are used in life science research, textiles, cosmetics, and biofuels.
- For instance, in life science research, synthetic enzymes such as CRISPR-associated nucleases like CAS9 are used for precise genome editing to make the required modification in DNA sequences of organisms.
- Genome editing has been extensively used in drug discovery and personalized medicine, thereby increasing the demand for synthetic enzymes.
By Technology
- The Gene Synthesis Segment to Dominate the Synthetic Biology Market
- The gene synthesis segment is expected to account for the largest share of the synthetic biology market.
- Gene synthesis refers to chemically synthesizing a strand of DNA base-by-base.
- The synthesized strand is then amplified with PCR and used for multiple applications.
- It is the fundamental step required in any genomic study.
- The large share of gene synthesis is attributed to accelerated life sciences R&D and emerging application areas like metabolic engineering.
- Synthetic genes enable researchers to use genetic constructs, bypassing the time-consuming process of cloning and assembling from the natural source.
- Thus, gene synthesis reduces the overall time required for cost-cutting and improves precision, owing to which its demand is the highest.
By Application
- The life science & healthcare application segment is expected to account for the largest share of 41% of the synthetic biology market.
- The large share is attributed to the availability of funding for life science & healthcare research, increasing demand for personalized therapies, and high disease prevalence necessitating newer therapies to be launched in the market.
- In June 2024, the Commonwealth Government’s Medical Research Future Fund (MRFF) (Australia) invested USD 9.75 million in establishing MedChem Australia, a new national medicinal chemistry initiative, to accelerate the identification of early-stage drug candidates.
- The use of synthetic biology products helps produce therapeutic proteins such as enzymes and antibodies in engineered microorganisms at low cost and on a large scale; thus, the adoption of synthetic biology tools is increasing in life science and healthcare.
By End User
- The Pharmaceutical, Biotechnology, & MedTech Companies Segment to Dominate the Synthetic Biology Market
- The pharmaceutical, biotechnology, & MedTech companies’ segment is expected to account for the largest share of the synthetic biology market.
- The large share of the segment is attributed to the need to develop new therapies owing to increasing disease prevalence and increased spending on pharmaceutical R&D.
- For instance, global pharmaceutical R&D expenditure is expected to reach USD 213 billion in 2026 from USD 179 billion in 2020 (Source: International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)).
- Additionally, pharmaceutical & biotechnology companies' shift from traditional screening methods to synthetic biology technologies such as high throughput screening (HTS) is contributing to the large share of the segment.
- Additionally, pharmaceutical & biotechnology, & MedTech companies are relying on synthetic biology for developing IVD tests, optimizing production processes, and designing novel therapeutics, further contributing to the large share of the segment.
- However, the academic & research institutes segment is projected to witness a considerable growth rate during the forecast period of 2025–2032.
- The academic & research institutes contribute to clinical research by using synthetic biology to engineer the biological system to study metabolic pathways, gene regulation, cellular signaling, and gene expression.
- In the case of clinical research, the contribution of academic institutes in initiating clinical trials is more as compared to commercial entities.
- Thus, with the growing need to accelerate and fast-track research across various industries, especially life sciences, the demand for synthetic biology products in academic & research institutes is expected to increase.
Geographic analysis
North America
Largest shareIn 2025, North America is expected to account for the largest share of the 36.8% of synthetic biology market. The large share of the region is attributed to the substantial R&D investments by life sciences companies for drug discovery & development, the presence of key market players in the region, government initiatives supporting research and development, accelerated research to develop biofuels, and high focus on the textile industry. The textile industry in the region is growing owing to the increasing spending on fashion and apparel among the middle-income population groups. For instance, exports of fibers, textiles and apparel were USD 34 billion in 2022 compared with USD 28.4 billion in 2021 (source: U.S. Department of Commerce data for Export Group). The region also leads in the advanced R&D in clinical research. The surge in R&D spending by pharmaceutical companies is anticipated to drive the demand for synthetic biology products, driving the market. According to the European Federation of Pharmaceutical Industries and Associations (Belgium), in the U.S., the pharmaceutical R&D expenditure annual growth rate was 15.6% from 2018-2022 compared to 13.6% from 2013-2017.
Asia-Pacific
Fastest growthMoreover, the market in Asia-Pacific is slated to register the highest growth rate of 24.9% during the forecast period. The countries in Asia-Pacific, including China, India, and South Korea, are projected to offer significant growth opportunities for the vendors in this market. The expansion in the end-use industries such as pharmaceutical, food, chemical, cosmetics, textile, and others are driving the demand for synthetic biology. The bio-textile industry is expanding in the region, and many players are investing in this area. For instance, in April 2025, Hyosung TNC (South Korea) invested USD 1 billion in bio-textile materials plants in Vietnam’s Ba Ria-Vung Tau province. The manufacturing plant is expected to be operational in 2026. Additionally, the demand for biofuel is expected to increase in India owing to the government policies mandating biofuels. In 2018 India launched a National Policy on Biofuels with a blending target for biodiesel (5% by 2032) and ethanol (20% blending by 2032). Such developments in the region drive the growth of the market in Asia-Pacific.
Competitive landscape
- November 2024
Synlogic, Inc. (U.S.) received a USD 2.5 million payment under the company’s collaboration with F. Hoffmann-La Roche AG (Switzerland). The company collaborated in 2021 to develop Synthetic Biotic medicine used in the treatment of inflammatory bowel disease (IBD).
- July 2024
Sumitomo Chemical Co., Ltd (Japan) collaborated with Ginkgo Bioworks (U.S.) to develop functional chemicals with synthetic biology.
- May 2024
Octarine Bio (Denmark) collaborated with Ginkgo Bioworks (U.S.) to engineer a strain that produces violacein and its derivatives, a naturally occurring bis-indole pigment for the textile industry.
- January 2024
Moderna, Inc. (U.S.) acquired OriCiro Genomics K.K. (Japan) for USD 85 million. OriCiro Genomics' biology and enzyme technologies will support Moderna's expanding portfolio of therapeutics and vaccines.
- Thermo Fisher Scientific Inc. (U.S.)
- Merck KGaA · Germany
- Agilent Technologies, Inc. (U.S.)
- Novozymes A/S · Denmark
- Codexis, Inc. (U.S.)
- Creative Biogene Inc. (U.S.)
- Amyris, Inc. (U.S.)
- Precigen, Inc. (U.S.)
- Illumina, Inc. (U.S.)
- New England Biolabs (U.S.)
- Ginkgo Bioworks (U.S.)
- Genscript Biotech Corp. (U.S.)
- Eurofins Scientific SE · France
- Twist Bioscience (U.S.)
Frequently asked questions
The Synthetic Biology Market encompasses the research, development, and application of synthetic biology techniques, which involve designing and engineering biological systems for various applications, including medicine, agriculture, and biofuels.
Cite this report
Meticulous Research. (2024). Synthetic Biology Market - Global Opportunity Analysis and Industry Forecast (2025-2032) (Report No. MRHC - 1041143). Meticulous Market Research Pvt. Ltd. https://www.meticulousresearch.com/product/synthetic-biology-market-5826